Oropharynx Squamous Cell Carcinoma Clinical Trials

22 clinical trials for Oropharynx Squamous Cell Carcinoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC — RECRUITING
• A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) — RECRUITING · PHASE2
• Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) — RECRUITING · PHASE2
• SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers — RECRUITING · PHASE2
• Detection of Oral and Throat Cancers Using OralViome Cancer Testing System — RECRUITING
• Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV) — RECRUITING
• First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients — ACTIVE_NOT_RECRUITING · PHASE2
• APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma — NOT_YET_RECRUITING · PHASE3
• A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer — TERMINATED · PHASE2
• Training Swallowing Initiation During Expiration — COMPLETED · NA
• Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer — COMPLETED · PHASE2
• Collagen Matrix in Oral Cancer Surgery — COMPLETED
• Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma — ACTIVE_NOT_RECRUITING · NA
• Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. — TERMINATED · PHASE2
• IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma — COMPLETED · PHASE1
• Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC — COMPLETED · NA
• Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer — COMPLETED · PHASE2
• A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers — WITHDRAWN · PHASE1
• Circulating Biomarkers in Oropharyngeal Cancers — ACTIVE_NOT_RECRUITING
• QUantitative Assessment of Swallowing After Radiation (QUASAR) — OTHER
• Saliva-based Detection of CD44 — COMPLETED
• Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell — OTHER

Refine this search